Cargando…

Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review

INTRODUCTION: Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes. METHODS: Efficacy of cyclosporine with and without systemic corticosteroids for alopecia areata was evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowaczyk, Joanna, Makowska, Karolina, Rakowska, Adriana, Sikora, Mariusz, Rudnicka, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211785/
https://www.ncbi.nlm.nih.gov/pubmed/32270396
http://dx.doi.org/10.1007/s13555-020-00370-2
_version_ 1783531516291186688
author Nowaczyk, Joanna
Makowska, Karolina
Rakowska, Adriana
Sikora, Mariusz
Rudnicka, Lidia
author_facet Nowaczyk, Joanna
Makowska, Karolina
Rakowska, Adriana
Sikora, Mariusz
Rudnicka, Lidia
author_sort Nowaczyk, Joanna
collection PubMed
description INTRODUCTION: Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes. METHODS: Efficacy of cyclosporine with and without systemic corticosteroids for alopecia areata was evaluated by a systematic review. Cochrane, EBSCOhost, Pubmed, Scopus and Web of Science databases were searched. Only studies published before January 2020 were included. RESULTS: A total of 2104 studies were initially examined, of which 14 were eligible for the systematic review. Among 340 reported cases, 213 had focal, multifocal or ophiasis form of alopecia areata, 60 were diagnosed with alopecia totalis and 67 with alopecia universalis. The mean response rate in the whole group of patients at the end of treatment was 65.00% (221/340; range 25–100%). Hair regrowth rate was higher in the group with cases of alopecia areata limited to scalp (124/165; mean 75.15%; range 40–100%) than in the cases with alopecia totalis (30/46; mean 65.22%; range 25–100%) or alopecia universalis (24/52; mean 46.15%; range 25–100%). The combined therapy with systemic corticosteroids was superior to the monotherapy (152/219; mean 69.41%; 0–80% vs. 69/121; mean 57.02%; range 6.67–100%) and had a lower recurrence rate (39/108; mean 36.11% vs. 34/46; mean 73.91%, respectively). The combined treatment with methylprednisolone was significantly more effective when compared to the cyclosporine monotherapy (124/183; mean 67.76%; range 0–80% vs. 69/121; mean 57.02%; range 6.67–100%). The mean time of treatment was 6.75 months (range 2–36). LIMITATIONS: Limitations of our study were the retrospective character of included studies, differences in doses of prescribed drugs, and duration of the treatment and follow-up times. CONCLUSION: Cyclosporine in combination with oral systemic corticosteroids is more effective than in monotherapy for severe alopecia areata.
format Online
Article
Text
id pubmed-7211785
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-72117852020-05-14 Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review Nowaczyk, Joanna Makowska, Karolina Rakowska, Adriana Sikora, Mariusz Rudnicka, Lidia Dermatol Ther (Heidelb) Review INTRODUCTION: Cyclosporine is commonly used in treatment for alopecia areata. It can be administered as a monotherapy or in combination with systemic corticosteroids, with various outcomes. METHODS: Efficacy of cyclosporine with and without systemic corticosteroids for alopecia areata was evaluated by a systematic review. Cochrane, EBSCOhost, Pubmed, Scopus and Web of Science databases were searched. Only studies published before January 2020 were included. RESULTS: A total of 2104 studies were initially examined, of which 14 were eligible for the systematic review. Among 340 reported cases, 213 had focal, multifocal or ophiasis form of alopecia areata, 60 were diagnosed with alopecia totalis and 67 with alopecia universalis. The mean response rate in the whole group of patients at the end of treatment was 65.00% (221/340; range 25–100%). Hair regrowth rate was higher in the group with cases of alopecia areata limited to scalp (124/165; mean 75.15%; range 40–100%) than in the cases with alopecia totalis (30/46; mean 65.22%; range 25–100%) or alopecia universalis (24/52; mean 46.15%; range 25–100%). The combined therapy with systemic corticosteroids was superior to the monotherapy (152/219; mean 69.41%; 0–80% vs. 69/121; mean 57.02%; range 6.67–100%) and had a lower recurrence rate (39/108; mean 36.11% vs. 34/46; mean 73.91%, respectively). The combined treatment with methylprednisolone was significantly more effective when compared to the cyclosporine monotherapy (124/183; mean 67.76%; range 0–80% vs. 69/121; mean 57.02%; range 6.67–100%). The mean time of treatment was 6.75 months (range 2–36). LIMITATIONS: Limitations of our study were the retrospective character of included studies, differences in doses of prescribed drugs, and duration of the treatment and follow-up times. CONCLUSION: Cyclosporine in combination with oral systemic corticosteroids is more effective than in monotherapy for severe alopecia areata. Springer Healthcare 2020-04-08 /pmc/articles/PMC7211785/ /pubmed/32270396 http://dx.doi.org/10.1007/s13555-020-00370-2 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Nowaczyk, Joanna
Makowska, Karolina
Rakowska, Adriana
Sikora, Mariusz
Rudnicka, Lidia
Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_full Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_fullStr Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_full_unstemmed Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_short Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
title_sort cyclosporine with and without systemic corticosteroids in treatment of alopecia areata: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211785/
https://www.ncbi.nlm.nih.gov/pubmed/32270396
http://dx.doi.org/10.1007/s13555-020-00370-2
work_keys_str_mv AT nowaczykjoanna cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT makowskakarolina cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT rakowskaadriana cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT sikoramariusz cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview
AT rudnickalidia cyclosporinewithandwithoutsystemiccorticosteroidsintreatmentofalopeciaareataasystematicreview